University of Southern California

  Award Total: $31,969,745 # of Awards: 87 Home Page:

Investigators

  Leslie Bernstein , Ph.D.- Catherine Carpenter , M.P.H., Ph.D.- Graham Casey , Ph.D.- Cheng-Ming Chuong , M.D., Ph.D.- Gerhard Coetzee , Ph.D.- Peter Danenberg , Ph.D.- Peter Danenberg , Ph.D.- Jaimie Davis , Ph.D.- David Delgado , Ph.D., M.P.H.- Shelley Enger , Ph.D.- Shelley Enger , Ph.D.- Heather Feigelson , Ph.D., M.P.H.- Heather Feigelson , Ph.D., M.P.H.- Silvia Formenti , M.D.- Silvia Formenti , M.D.- Silvia Formenti , M.D.- Gary Fujii , Ph.D.- Agustin Garcia , M.D.- Christopher Haiman , Sc.D.- Fred Hall , Ph.D.- Ann Hamilton , Ph.D.- Ann Hamilton , Ph.D.- Brian Henderson , M.D.- Brian Henderson , M.D.- Brian Henderson , M.D.- Brian Henderson , M.D.- Colin Hill , Ph.D.- Deirdre Hill , Ph.D.- Florence Hofman , Ph.D.- Dennis Holmes , M.D.- Syed Ashraf Imam , M.S., Ph.D.- Sue Ann Ingles , DrPH- Sue Ann Ingles , DrPH- Sue Ann Ingles , DrPH- Sue Ann Ingles , DrPH- Jill Johnston , Ph.D.- Noriyuki Kasahara , M.D., Ph.D.- Carol Koprowski , Ph.D., R.D.- Julie Lang , M.D.- Eunjung Lee , - Amy Lee , Ph.D.- Eunjung Lee , - Thomas Mack , M.D., M.P.H.- Thomas Mack , M.D., M.P.H.- Francis Markland , Ph.D.- Francis Markland , Ph.D.- Francis Markland , Ph.D.- Beth Meyerowitz , Ph.D.- Kristine Monroe , Ph.D.- Kristine Monroe , Ph.D.- Kristine Monroe , Ph.D.- Franco Muggia , M.D.- Franco Muggia , M.D.- Elizabeth Osth-Lillie , M.S.- Malcolm Pike , Ph.D.- Malcolm Pike , Ph.D.- Malcolm Pike , Ph.D.- Michael Press , M.D., Ph.D.- Michael Press , M.D., Ph.D.- Michael Press , M.D., Ph.D.- Michael Press , M.D., Ph.D.- Michael Press , M.D., Ph.D.- Michael Press , M.D., Ph.D.- Michael Press , M.D., Ph.D.- Nicole Probst-Hensch , Ph.D.- Judd Rice , Ph.D.- Ronald Ross , M.D.- Ronald Ross , M.D.- Ronald Ross , M.D.- Axel Schonthal , Ph.D.- Lisa Shames , Ph.D., M.P.H.- Lisa Shames , Ph.D., M.P.H.- Wei-Chiang Shen , Ph.D.- Darryl Shibata , M.D.- Manbir Singh , Ph.D.- Michael Stallcup , Ph.D.- Daniel Stram , Ph.D.- Stephen Swenson , Ph.D.- Debasish Tripathy , M.D.- Giske Ursin , M.D., Ph.D.- Wei Wang , M.D.- Wei Wang , M.D.- Jeffrey Weber , M.D., Ph.D.- Donna Williams-Hill , Ph.D.- Donna Williams-Hill , Ph.D.- Donna Williams-Hill , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Anna Wu , Ph.D.- Qing Zhou , M.D., Ph.D-

Grants

Title[sort] Cycle Award[sort]
Assessing breast health in urban oil drilling communities 2018 (Cycle 24) $165,000
 Investigator(s): Jill Johnston, Ph.D. 24AB-1600
A prospective study of phthalates, BPA, and breast cancer 2016 (Cycle 22) $1,603,826
 Investigator(s): Anna Wu, Ph.D. 22UB-2309
Gut microbiota in association with chemotherapy treatment 2014 (Cycle 20) $246,936
 Investigator(s): Anna Wu, Ph.D. 20IB-0105
Persistent organic pollutants and mammographic density 2014 (Cycle 20) $247,534
 Investigator(s): Eunjung Lee, 20IB-0114
Intranasal drug delivery for brain metastatic breast cancer 2013 (Cycle 19) $242,382
 Investigator(s): Axel Schonthal, Ph.D. 19IB-0141
Expression Profiling of Circulating Tumor Cells 2013 (Cycle 19) $244,591
 Investigator(s): Julie Lang, M.D. 19IB-0112
Co-Targeting the Notch and EphB4 Receptors in Breast Cancer 2012 (Cycle 18) $243,362
 Investigator(s): Debasish Tripathy, M.D. 18IB-0048
Predicting BRCA1 Mutation Status from Tumor Pathology 2012 (Cycle 18) $245,821
 Investigator(s): Ann Hamilton, Ph.D. 18IB-0005
Soy, DNA Methylation and Breast Cancer 2011 (Cycle 17) $244,524
 Investigator(s): Anna Wu, Ph.D. 17IB-0017
HER2 Co-Amplified Genes and Treatment Response 2010 (Cycle 16) $241,988
 Investigator(s): Michael Press, M.D., Ph.D. 16IB-0098
California Breast Cancer Survivorship Consortium - USC MEC 2010 (Cycle 16) $216,332
 Investigator(s): Kristine Monroe, Ph.D. 16ZB-8005
Receptor Re-expression in ER and PR Negative Breast Cancer 2010 (Cycle 16) $18,203
 Investigator(s): Agustin Garcia, M.D. 16IB-0106
California Breast Cancer Survivorship Consortium - USC AABCS 2010 (Cycle 16) $1,006,035
 Investigator(s): Anna Wu, Ph.D. 16ZB-8001
Race & Ethnicity in Stage-specific Breast Cancer Survival 2009 (Cycle 15) $26,943
 Investigator(s): Kristine Monroe, Ph.D. 15QB-8205
Race & Ethnicity in Stage-specific Breast Cancer Survival 2009 (Cycle 15) $166,003
 Investigator(s): Anna Wu, Ph.D. 15QB-8201
Podocalyxin as a Basal-like Breast Cancer Stem Cell Marker 2009 (Cycle 15) $243,676
 Investigator(s): Graham Casey, Ph.D. 15IB-0076
New Methods for Genomic Studies in African American Women 2009 (Cycle 15) $411,297
 Investigator(s): Daniel Stram, Ph.D. 15UB-8402
Soy Treatment for High-risk Women and DCIS Patients 2009 (Cycle 15) $1,203,132
 Investigator(s): Anna Wu, Ph.D. 15OB-0162
Topoisomerase-IIa as a Predictor of Anthracycline Response 2008 (Cycle 14) $405,393
 Investigator(s): Michael Press, M.D., Ph.D. 14NB-0179
Genes in Hormone Metabolism Pathway and Breast Cancer 2008 (Cycle 14) $134,996
 Investigator(s): Eunjung Lee, 14FB-0104
Grapefruit, Hormones, and Postmenopausal Breast Cancer Risk 2008 (Cycle 14) $243,717
 Investigator(s): Kristine Monroe, Ph.D. 14IB-0019
Circuit Training to Lower Breast Cancer Risk in Latina Teens 2007 (Cycle 13) $244,374
 Investigator(s): Jaimie Davis, Ph.D. 13IB-0065
rADDs: Novel Disintegrins Targeting Breast Cancer 2006 (Cycle 12) $244,500
 Investigator(s): Stephen Swenson, Ph.D. 12IB-0153
Topoisomerase-IIa as a Predictor of Anthracycline Response 2006 (Cycle 12) $244,499
 Investigator(s): Michael Press, M.D., Ph.D. 12IB-0155
Histone Methylation as a Marker of Breast Cancer Progression 2005 (Cycle 11) $162,500
 Investigator(s): Judd Rice, Ph.D. 11IB-0085
Androgen Receptor Gene and p21 Gene in Breast Cancer 2005 (Cycle 11) $34,293
 Investigator(s): Wei Wang, M.D. 11FB-0133
Survivin: Target for Breast Cancer Brain Metastases 2005 (Cycle 11) $242,854
 Investigator(s): Florence Hofman, Ph.D. 11IB-0145
Tea, Genes and Their Interactions on Breast Cancer 2004 (Cycle 10) $1,610,872
 Investigator(s): Anna Wu, Ph.D. 10PB-0098
Prolactin and Breast Cancer Risk in a Multiethnic Cohort 2003 (Cycle IX) $160,843
 Investigator(s): Brian Henderson, M.D. 9IB-0034
Lifestyle Factors & Breast Ca Prognosis in Asian-Americans 2003 (Cycle IX) $1,050,107
 Investigator(s): Anna Wu, Ph.D. 9PB-0089
Common Genetic Variation & Breast Cancer: A Genomic Approach 2003 (Cycle IX) $462,925
 Investigator(s): Christopher Haiman, Sc.D. 9KB-0006
Androgen Receptor Gene and PSA Gene in Breast Cancer Risk 2002 (Cycle VIII) $59,557
 Investigator(s): Wei Wang, M.D. 8GB-0103
USC/NCCC Breast Cancer Research Training Program 2002 (Cycle VIII) $266,759
 Investigator(s): Michael Press, M.D., Ph.D. 8TB-0097
Fiber, Estrogen and Breast Cancer in Mexican American Women 2002 (Cycle VIII) $159,117
 Investigator(s): Malcolm Pike, Ph.D. 8WB-0066
The Androgen Receptor and Mammographic Density 2002 (Cycle VIII) $59,868
 Investigator(s): Elizabeth Osth-Lillie, M.S. 8GB-0010
Dietary Fat, Fat Metabolizing Genes and Breast Cancer Risk 2001 (Cycle VII) $383,740
 Investigator(s): Sue Ann Ingles, DrPH 7WB-0110
HER-2/neu Gene Variations and Breast Cancer Risk 2001 (Cycle VII) $1,182,463
 Investigator(s): Michael Press, M.D., Ph.D. 7PB-0051S
Mammography Density and Sex Steroid Genes 2000 (Cycle VI) $102,328
 Investigator(s): Sue Ann Ingles, DrPH 6IB-0093
DNA Polymorphisms and Breast Cancer in a Multi-ethnic Cohort 2000 (Cycle VI) $80,949
 Investigator(s): Brian Henderson, M.D. 6IB-0070
Mammographic Density, HRT and Hormonal Activity Genes 2000 (Cycle VI) $708,225
 Investigator(s): Thomas Mack, M.D., M.P.H. 6PB-0052
Molecular Staging of Breast Cancer Progression 2000 (Cycle VI) $244,320
 Investigator(s): Cheng-Ming Chuong, M.D., Ph.D. 6JB-0030
Stress Protein and Drug Resistance in Human Breast Cancer 2000 (Cycle VI) $325,873
 Investigator(s): Amy Lee, Ph.D. 6JB-0001
Targeted Delivery of an Anti-breast Tumor Agent 2000 (Cycle VI) $684,291
 Investigator(s): Francis Markland, Ph.D. 6EB-0059
Targeted Delivery of an Anti-breast Tumor Agent 2000 (Cycle VI) $684,291
 Investigator(s): Gary Fujii, Ph.D. 6EB-0059
Targeted Delivery of an Anti-breast Tumor Agent 2000 (Cycle VI) $684,291
 Investigator(s): Noriyuki Kasahara, M.D., Ph.D. 6EB-0059
Arginine Deiminase as an Innovative Anti-Breast Cancer Agent 2000 (Cycle VI) $81,507
 Investigator(s): Wei-Chiang Shen, Ph.D. 6IB-0045
Upregulation of BRCA1 as a Cancer Preventive Strategy 2000 (Cycle VI) $610,319
 Investigator(s): Colin Hill, Ph.D. 6PB-0126
Postmenopausal Breast Cancer: Obesity & the Leptin Receptor 1999 (Cycle V) $97,677
 Investigator(s): Leslie Bernstein, Ph.D. 5IB-0098
IGF System and Breast Cancer in Postmenopausal Women 1999 (Cycle V) $122,041
 Investigator(s): Brian Henderson, M.D. 5JB-0095
Breast Cancer Susceptibility Genes in Very High Risk Women 1999 (Cycle V) $129,247
 Investigator(s): Ann Hamilton, Ph.D. 5IB-0116
Exercise, Hormones and Breast Cancer Prevention 1999 (Cycle V) $142,451
 Investigator(s): Donna Williams-Hill, Ph.D. 5IB-0127
Can Molecular Markers Predict Response to Adjuvant Therapy? 1999 (Cycle V) $508,813
 Investigator(s): Michael Press, M.D., Ph.D. 5EB-3101
Estrogen metabolizing genes, soy and breast cancer in Asians 1999 (Cycle V) $1,664,130
 Investigator(s): Anna Wu, Ph.D. 5PB-0018
Breast Cancer Survivorship: Partner's Role in Recovery 1999 (Cycle V) $610,760
 Investigator(s): Beth Meyerowitz, Ph.D. 5PB-0172
Mechanism of Novel Anti-Angiogenic Therapy for Breast Cancer 1998 (Cycle IV) $324,300
 Investigator(s): Francis Markland, Ph.D. 4CB-0083
Biologic Determinants of Response to Paclitaxel & Radiation 1998 (Cycle IV) $595,661
 Investigator(s): Silvia Formenti, M.D. 4EB-6000
Biologic Determinants of Response to Paclitaxel & Radiation 1998 (Cycle IV) $595,661
 Investigator(s): Peter Danenberg, Ph.D. 4EB-6000
Biologic Determinants of Response to Paclitaxel & Radiation 1998 (Cycle IV) $595,661
 Investigator(s): Franco Muggia, M.D. 4EB-6000
Radiation, Reproductive & Menstrual Factors & Breast Cancer 1998 (Cycle IV) $60,604
 Investigator(s): Deirdre Hill, Ph.D. 4FB-0123
Exercise and Risk of Breast Cancer Recurrence 1998 (Cycle IV) $236,299
 Investigator(s): Malcolm Pike, Ph.D. 4JB-0048
Multi-ethnic Study of Genetic Control of Plasma Hormones 1998 (Cycle IV) $141,639
 Investigator(s): Heather Feigelson, Ph.D., M.P.H. 4KB-0147
Oral Contraceptives, Hormonal Risk Factors and BRCA1 1998 (Cycle IV) $1,693,685
 Investigator(s): Giske Ursin, M.D., Ph.D. 4PB-0092
NCCC Breast Cancer Research Training Program 1998 (Cycle IV) $339,527
 Investigator(s): Ronald Ross, M.D. 4TB-0153
Estrogen Formation and Breast Cancer Risk 1997 (Cycle III) $244,889
 Investigator(s): Gerhard Coetzee, Ph.D. 3IB-0082
Vitamin D Receptor Gene and Breast Cancer Risk 1997 (Cycle III) $241,803
 Investigator(s): Sue Ann Ingles, DrPH 3IB-0089
Mammogram Density, Cancer, Inheritance & Acquired Risk:Twins 1997 (Cycle III) $1,265,784
 Investigator(s): Thomas Mack, M.D., M.P.H. 3PB-0029
Gene-Diet/Tobacco Interactions in Breast Cancer in Asians 1997 (Cycle III) $745,223
 Investigator(s): Anna Wu, Ph.D. 3PB-0102
Biochemical Correlates for Clinical Response to Paclitaxel 1997 (Cycle III) $110,390
 Investigator(s): Silvia Formenti, M.D. 3DB-0045
Physical Activity, Diet and Menarche in a Multiethnic Cohort 1997 (Cycle III) $75,546
 Investigator(s): Carol Koprowski, Ph.D., R.D. 3FB-0065
Hormone Receptors and Breast Cancer Survival 1997 (Cycle III) $5,862
 Investigator(s): Shelley Enger, Ph.D. 3FB-0097
Breast Cancer Gene Therapy Using a Metastasis Inhibitor 1997 (Cycle III) $75,599
 Investigator(s): Qing Zhou, M.D., Ph.D 3FB-0125
Peptide-pulsed Dendritic Cell Therapy for Breast Cancer 1997 (Cycle III) $293,506
 Investigator(s): Jeffrey Weber, M.D., Ph.D. 3CB-0013
BRCA1 regulation in breast cancer: a rat mammary model 1996 (Cycle II) $368,159
 Investigator(s): Donna Williams-Hill, Ph.D. 2KB-0232
Early detection of breast cancer and its recurrence 1996 (Cycle II) $271,619
 Investigator(s): Syed Ashraf Imam, M.S., Ph.D. 2RB-0002
Mammographic Densities and Breast Cancer Prevention 1996 (Cycle II) $567,993
 Investigator(s): Malcolm Pike, Ph.D. 2RB-0058
Estrogen receptor-interacting proteins in breast cancer 1996 (Cycle II) $492,719
 Investigator(s): Michael Stallcup, Ph.D. 2RB-0174
High Resolution Breast Gamma Emission Imaging System 1996 (Cycle II) $309,228
 Investigator(s): Manbir Singh, Ph.D. 2RB-0188
Radiosurgery of early breast cancer 1996 (Cycle II) $76,713
 Investigator(s): Silvia Formenti, M.D. 2CB-0224
Genetic Susceptibility to Breast Cancer 1996 (Cycle II) $75,436
 Investigator(s): Heather Feigelson, Ph.D., M.P.H. 2FB-0212
Breast Cancer and Genetic Differences in Estrogen Formation 1996 (Cycle II) $81,598
 Investigator(s): Nicole Probst-Hensch, Ph.D. 2IB-0019
USC/Norris Breast Cancer Research Training Program 1995 (Cycle I) $301,138
 Investigator(s): Ronald Ross, M.D. 1TB-0091
Breast Cancer Progression and the Extracellular Matrix 1995 (Cycle I) $493,643
 Investigator(s): Francis Markland, Ph.D. 1RB-0052
Genes Which Cause Increased Cellular DNA in Breast Cancer 1995 (Cycle I) $493,585
 Investigator(s): Michael Press, M.D., Ph.D. 1RB-0203
Case-Control Study of Breast Cancer in Asian-American Women 1995 (Cycle I) $639,651
 Investigator(s): Anna Wu, Ph.D. 1RB-0287
Biology of Telomere Length Conservation in Breast Cancer 1995 (Cycle I) $78,798
 Investigator(s): Darryl Shibata, M.D. 1IB-0121
Vitamin D & Genetics of Vitamin D Receptor in Breast Cancer 1995 (Cycle I) $80,976
 Investigator(s): Sue Ann Ingles, DrPH 1IB-0353
Exercise and the Prevention of Breast Cancer 1995 (Cycle I) $367,464
 Investigator(s): Lisa Shames, Ph.D., M.P.H. 1KB-0060
Race/Ethnicity and Late Stage Breast Cancer 1995 (Cycle I) $123,127
 Investigator(s): David Delgado, Ph.D., M.P.H. 1KB-0152
Physical Activity: Impact on Hormones and Breast Cancer Risk 1995 (Cycle I) $60,023
 Investigator(s): Catherine Carpenter, M.P.H., Ph.D. 1FB-0202
Alcohol Intake & Risk of Estrogen-Receptor Positive Br Ca 1995 (Cycle I) $73,996
 Investigator(s): Shelley Enger, Ph.D. 1FB-0341
Genetic Susceptibility to Breast Cancer 1995 (Cycle I) $79,669
 Investigator(s): Brian Henderson, M.D. 1IB-0084